There is a potential safety signal when the COVID-19 vaccine is administered to young adult female (30–49years old), resulting in menstrual disorders in. However, due to the well-known limitations of spontaneous reporting data, it is challenging to explicity classify menstrual disorders as an ...
13. Katz SL. 2004. From culture to vaccine-Salk and Sabin. N Engl J Med. 351:1485–1487. 14. Pfeffermann D. 1996. The use of sampling weights for survey data analysis. Stat Methods Med Res. 5(3):239–261. 15. Cugnata ...
13. Katz SL. 2004. From culture to vaccine-Salk and Sabin. N Engl J Med. 351:1485–1487. 14. Pfeffermann D. 1996. The use of sampling weights for survey data analysis. Stat Methods Med Res. 5(3):239–261. 15. Cugnata F et al. 2021. A propensity score approach for treatment e...
46. Kenett RS, Manzi G, Rapaport C, Salini S. 2022. Integrated analysis of behavioral and health COVID-19 data combining Bayesian networks and structural equation models. Int J Environ Res Publ Health. 19(8):4859. https://www.mdpi.com/1660-4601/19/ 8/4859/htm, https://www.mdpi.com...
Updated monovalent COVID-19 vaccines have beenrecommended for all agessince this past September. Forrest said studying an older version of the vaccine does provide valuable insight. “The strength of the messenger RNA technology is that it can be rapidly adapted to changing viral variants,” Forres...
为应对 COVID-19 大流行,许多国家目前正在进行大规模的 COVID-19 疫苗接种。在这里,我们报告了健康志愿者接种灭活 SARS-CoV-2 疫苗后,除了产生中和抗体外,血红蛋白 A1c、血清钠和钾水平、凝血曲线和肾功能的持续变化。在 COVID-19 患者中也报告了类似的变化,这表明疫苗接种模仿了感染。第一次接种前和接种后 ...
Although the national average indicated that approximately 50 percent of deaths were preventable, researchers said there were large differences among states - ranging from 25 percent to 74 percent vaccine-preventable deaths, according to the report. ...
vaccine efficacy remains to be determined. It is also rather interesting that while cohorts A and B had different anti-SARS-CoV-2 antibody production profiles, their PBMCs scRNA-seq results were drastically similar, includ...
19 vaccines. In this review, we provided an up-to-date summary for current COVID-19 vaccines, discussed the biological basis and clinical impact of SARS-CoV-2 variants and subvariants, and analyzed the effectiveness of various vaccine booster regimens against different SARS-CoV-2 strains. ...
An Analysis of the Willingness to the COVID-19 Vaccine Booster Shots among Urban Employees: Evidence from a Megacity H in Eastern China. Int. J. Environ. Res. Public Health 2022, 19, 2300. [Google Scholar] [CrossRef] Abebe, H.; Shitu, S.; Mose, A. Understanding of COVID-19 ...